miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients

Carcinogenesis

Volumn 36, Issue 6, 2015, Pages 676-684

  Zou, Yongkang ^a   Li, Jianwei ^a   Chen, Zhiyu ^a   Li, Xiaowu ^a   Zheng, Shuguo ^a   Yi, Dong ^a   Zhong, Ai ^a   Chen, Jian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; MICRORNA; MICRORNA 29C; UNCLASSIFIED DRUG; MIRN29 MICRORNA, HUMAN; MMP2 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL SELECTION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; CELL MOTION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; LIVER; LIVER TUMOR; MIDDLE AGED; NUDE MOUSE; PANCREAS; PANCREAS TUMOR; PATHOLOGY; SECONDARY; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREAS; PANCREATIC NEOPLASMS;

EID: 84941620550     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv027     Document Type: Article

References (36)

1. Siegel, R. et al. (2012) Cancer statistics, 2012. CA. Cancer J. Clin., 62, 10-29.
2. Li, D. et al. (2004) Pancreatic cancer. Lancet, 363, 1049-1057.
3. Cascinu, S. et al. (2010) Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 21 (suppl. 5), v55-v58.
4. Kessenbrock, K. et al. (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell, 141, 52-67.
5. Jezierska, A. et al. (2009) Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med. Sci. Monit., 15, RA32-RA40.
6. Kurihara, Y. et al. (2009) Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 production and activation. Clin. Exp. Metastasis, 26, 425-432.
7. Taniwaki, K. et al. (2007) Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice. Cancer Res., 67, 4311-4319.
8. Mohammad, M.A. et al. (2012) Clinical relevance of cyclooxygenase-2 and matrix metalloproteinases (MMP-2 and MT1-MMP) in human breast cancer tissue. Mol. Cell. Biochem., 366, 269-275.
9. Giannelli, G. et al. (2002) Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. Int. J. Cancer, 97, 425-431.
10. Giannopoulos, G. et al. (2008) The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters. Anticancer Res., 28, 1875-1881.
11. Wang, L.B. et al. (2008) Changes of histology and expression of MMP-2 and nm23-H1 in primary and metastatic gastric cancer. World J. Gastroenterol., 14, 1612-1616.
12. Mroczko, B. et al. (2011) Clinical significance of serum levels of matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor (TIMP-2) in gastric cancer. Folia Histochem. Cytobiol., 49, 125-131.
13. Huang, K.J. et al. (2012) The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer. Med. Oncol., 29, 318-323.
14. Noh, S. et al. (2011) MMP-2 as a putative biomarker for carcinomatosis in gastric cancer. Hepatogastroenterology., 58, 2015-2019.
15. Mendes, O. et al. (2007) MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2. Clin. Exp. Metastasis, 24, 341-351.
16. Mendes, O. et al. (2005) Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clin. Exp. Metastasis, 22, 237-246.
17. Chen, J. et al. (2009) Role of fibrillar Tenascin-C in metastatic pancreatic cancer. Int. J. Oncol., 34, 1029-1036.
18. Inui, M. et al. (2010) MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol., 11, 252-263.
19. Bartel, D.P. (2009) MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-233.
20. van Rooij, E. et al. (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. USA, 105, 13027-13032.
21. Wang, C.M. et al. (2011) miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma. Biochem. Biophys. Res. Commun., 411, 586-592.
22. Wang, H. et al. (2013) miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin ß1 and matrix metalloproteinase2 (MMP2). PLoS One, 8, e70192.
23. Ru, P. et al. (2012) miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling. Mol. Cancer Ther., 11, 1166-1173.
24. Sipos, B. et al. (2003) A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch., 442, 444-452.
25. Gold, D.V. et al. (1995) Targeting of xenografted pancreatic cancer with a new monoclonal antibody, PAM4. Cancer Res., 55, 1105-1110.
26. Lin, M. et al. (2011) MicroRNA expression profiles in human colorectal cancers with liver metastases. Oncol. Rep., 25, 739-747.
27. Fang, J.H. et al. (2011) MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology, 54, 1729-1740.
28. Han, T.S., et al. (2014) MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1. Gut., 64, 203-214
29. Lu, L. et al. (2014) MicroRNA-29a upregulates MMP2 in oral squamous cell carcinoma to promote cancer invasion and anti-apoptosis. Biomed. Pharmacother., 68, 13-19.
30. Cullingworth, J. et al. (2002) Carcinogen-induced pancreatic lesions in the mouse: effect of Smad4 and Apc genotypes. Oncogene, 21, 4696-4701.
31. Kojima, K. et al. (2007) Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia. Cancer Res., 67, 8121-8130.
32. Eibl, G. et al. (2005) A xenograft nude mouse model for perineural invasion and recurrence in pancreatic cancer. Pancreas, 31, 258-262.
33. Bos, P.D., et al. (2009) Genes that mediate breast cancer metastasis to the brain. Nature, 459, 1005-U137.
34. Minn, A.J. et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature, 436, 518-524.
35. Kang, Y. et al. (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell, 3, 537-549.
36. Ding, Q. et al. (2011) APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. J. Clin. Invest., 121, 4526-4536.